SAN FRANCISCO, Nov 28, 2020 (GLOBE NEWSWIRE) – Hagens Berman calls on Precigen, Inc. (N.ASDAQ:: PGEN) (f / k / a Intrexon) Investors with significant losses, to file your losses now. A securities fraud class action has been filed and certain investors may face sufficient losses to move on behalf of the lead plaintiff.
great Period: May 10, 2017 – September 25, 2020
Deadline of the main plaintiff: 4th December 2020
Contact an attorney now:: [email protected] | 844-916– –0895
Precigen, Inc. (PGEN) Class action against securities fraud::
The complaint alleges that Defendants have misrepresented and concealed the following: (1) The Company used pure methane as the feedstock for its advertised revenues for its Methanotrophic Bioconversion (“MCB”) platform instead of natural gas. (2) the yields from natural gas as the feedstock were significantly lower than the announced yields of pure methane; (3) Due to the significant price difference between pure methane and natural gas, pure methane was not a commercially viable feedstock. (4) The company’s financial statements for the first quarter of 2018 were incorrect. (5) The Company had significant weaknesses in its internal controls over financial reporting. and (6) the company has been under investigation by the SEC since October 2018.
Investors allegedly began to learn the truth through a series of disclosures that began on August 9, 2018, when the company announced it could no longer rely on them for financial results for the first quarter of 2018. In the adjusted results for the first quarter of 2018, the company made significant changes to prepaid expenses, income from collaboration and licensing, and the accumulated deficit, and admitted significant weaknesses in internal control over financial reporting.
On March 2, 2020, the company announced that it had received a subpoena from the SEC in October 2018 regarding Precigen’s MCB-related disclosures.
Finally, on September 25, 2020, the SEC issued an injunction that “contained inaccurate reports on the company’s alleged success in converting relatively inexpensive natural gas into more expensive industrial chemicals using a proprietary product [MCB] Program.”
“We’re focusing on investor losses and proving that Precigen boiled up its books and advertised fake technology,” said Reed Kathrein, the Hagens Berman partner who led the investigation.
If you are a Precigen investor and experience significant losses or have knowledge that may aid the company’s investigation, click here to discuss your statutory rights with Hagens Berman.
Whistleblower: Individuals with nonpublic information about Precigen should consider their options to help with the investigation or to use the SEC’s whistleblower program. Under the new program, whistleblowers who provide original information can receive rewards of up to 30 percent for each successful SEC recovery. Further information is available from Reed Kathrein at 844– –916– –0895 or send an email to [email protected]
About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities across the country and eighty attorneys. The firm represents investors, whistleblowers, employees and consumers in complex legal disputes. More information about the company and its achievements can be found at hbsslaw.com. For the latest news, visit our newsroom or follow us on Twitter @classactionlaw.
Reed Kathrein, 844-916-0895